Proteomic analysis of serum cytokine levels in response to highly active antiretroviral therapy (HAART)

被引：14
|
作者：
Relucio, KI
Beernink, HT
Chen, D
Israelski, DM
Kim, R
Holodniy, M
机构：
[1] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA USA
[2] Zyomyx Inc, Hayward, CA USA
[3] San Mateo Clin Trials & Res Unit, San Mateo, CA USA
[4] Vet Affairs Palo Alto Hlth Care Syst, AIDS Res Ctr, Palo Alto, CA USA
来源：
JOURNAL OF PROTEOME RESEARCH | 2005年 / 4卷 / 02期
关键词：
HIV; HAART; cytokines; antiretroviral therapy; proteomic chip; protein microarray; MIG; IP-10; CXCL9; CXCL10;
D O I：
10.1021/pr049930y
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
A 30-cytokine protein microarray was used to screen for cytokine profile changes in HIV-infected patients in response to highly active antiretroviral therapy (HAART). Serum cytokines showing significant changes were confirmed by enzyme immunoassay. Monokine induced by gamma-interferon (MIG) and interferon-inducible protein-10 (IP-10) levels significantly decreased after 24 weeks of HAART. Protein microarrays are useful for initial screening of novel cytokine expression. Further studies are needed to elucidate the role of MIG and IP-10 in response to HAART.
引用
收藏
页码：227 / 231
页数：5
相关论文
共 50 条
  • [1] Variations in patterns of highly active antiretroviral therapy (HAART) adherence
    Levine, AJ
    Hinkin, CH
    Castellon, SA
    Mason, KI
    Lam, MN
    Perkins, A
    Robinet, M
    Longshore, D
    Newton, T
    Myers, H
    Durvasula, RS
    Hardy, DJ
    AIDS AND BEHAVIOR, 2005, 9 (03) : 355 - 362
  • [2] Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?
    Bassetti, S
    Battegay, M
    Furrer, H
    Rickenbach, M
    Flepp, M
    Kaiser, L
    Telenti, A
    Vernazza, PL
    Bernasconi, E
    Sudre, P
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (02) : 114 - 119
  • [3] Adherence to Highly Active Antiretroviral Therapy (HAART): A Meta-Analysis
    Ortego, Carmen
    Huedo-Medina, Tania B.
    Llorca, Javier
    Sevilla, Lourdes
    Santos, Pilar
    Rodriguez, Elias
    Warren, Michelle R.
    Vejo, Javier
    AIDS AND BEHAVIOR, 2011, 15 (07) : 1381 - 1396
  • [4] Variations in Patterns of Highly Active Antiretroviral Therapy (HAART) Adherence
    Andrew J. Levine
    Charles H. Hinkin
    Steven A. Castellon
    Karen I. Mason
    Mona N. Lam
    Adam Perkins
    Marta Robinet
    Douglas Longshore
    Thomas Newton
    Hector Myers
    Ramani S. Durvasula
    David J. Hardy
    AIDS and Behavior, 2005, 9 : 355 - 362
  • [5] Adherence to Highly Active Antiretroviral Therapy (HAART): A Meta-Analysis
    Carmen Ortego
    Tania B. Huedo-Medina
    Javier Llorca
    Lourdes Sevilla
    Pilar Santos
    Elías Rodríguez
    Michelle R. Warren
    Javier Vejo
    AIDS and Behavior, 2011, 15 : 1381 - 1396
  • [6] Spontaneous apoptosis and highly active antiretroviral therapy (HAART)
    Dieye, TN
    Van Vooren, JP
    Delforge, ML
    Liesnard, C
    Devleeschouwer, M
    Farber, CM
    BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (01) : 16 - 20
  • [7] Gynaecomastia associated with highly active antiretroviral therapy (HAART)
    Meerkotter, Debra
    JOURNAL OF RADIOLOGY CASE REPORTS, 2010, 4 (07): : 34 - 40
  • [8] Healthcare use by varied highly active antiretroviral therapy (HAART) strata:: HAART use, discontinuation, and naivety
    Palacio, H
    Li, XH
    Wilson, TE
    Sacks, H
    Cohen, MH
    Richardson, J
    Young, M
    Muñoz, A
    AIDS, 2004, 18 (04) : 621 - 630
  • [9] Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status
    Kwara, A
    Flanigan, TP
    Carter, EJ
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (03) : 248 - 257
  • [10] A comparison of exposure groups in the EuroSIDA study: Starting highly active antiretroviral therapy (HAART), response to HAART, and survival
    Mocroft, A
    Madge, S
    Johnson, AM
    Lazzarin, A
    Clumeck, N
    Goebel, FD
    Viard, JP
    Gatell, J
    Blaxhult, A
    Lundgren, JD
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 22 (04) : 369 - 378
12345